The Florida denial segment captures a specific configuration: the member holds a fully-insured OIR-regulated plan issued in Florida (Aetna, Blue Cross and Blue Shield of Florida / Florida Blue, Cigna, Humana, UnitedHealthcare), or an AHCA-regulated managed-care plan (Florida Medicaid managed care, Ambetter from Sunshine Health for ACA marketplace), or a Knox-Keene-licensed subsidiary’s Florida product. The denial reason will track the carrier’s internal reason code (medical necessity, prior authorization, step therapy, formulary exclusion, out-of-network), but the appeal frameworks that attach are Florida-specific. The Florida Office of Insurance Regulation (OIR) regulates carriers under Florida Statutes Chapter 627 (the Florida Insurance Code), with § 627.613 spelling out the carrier’s standards for prompt investigation and payment of claims, § 627.6145 imposing utilization-review program standards, and § 627.646 establishing the external-review pathway — 4-month filing window from the carrier’s final internal-appeal denial — through an Independent Review Organization (IRO) certified or approved by OIR. The OIR Consumer Services line is the front door for Florida members — 1-877-693-5236, online complaint form at floir.com.
OIR-regulated carriers operating in Florida — Aetna, Florida Blue (Blue Cross and Blue Shield of Florida), Cigna, Humana, UnitedHealthcare’s fully-insured FL products — are subject to Florida Statutes § 627.6145 (utilization-review program standards) and § 627.646 (external review), which layer on top of any federal regime: a 60-day first-stage internal-appeal window after the ABD, a 4-month external review (IRO) deadline from the carrier’s final internal-appeal denial, and a 24-hour expedited external review under § 627.613 where ongoing care is at stake. The OIR Consumer Services line at 1-877-693-5236 routes the enrollee to the IRO request, and the certified IRO list maintained by OIR governs the external-review step. The Florida complaint pathway runs parallel to the federal 4-month ACA external-review window at 45 C.F.R. § 147.136(d) for ACA marketplace plans, and the most protective of the two carries the day.
Self-funded ERISA plans — the typical larger-employer group plan where the employer pays the claims rather than buying insurance from a carrier — fall outside OIR jurisdiction and outside § 627.646, and run through the federal ERISA § 503 claims-procedure rule at 29 C.F.R. § 2560.503-1, with the 4-month federal external-review channel at 29 C.F.R. § 2590.715-2719 for non-grandfathered plans and ERISA § 502(a) civil action at 29 U.S.C. § 1132(a)(1)(B) as the post-exhaustion remedy. FL UR laws (§ 627.6145 et seq.) still apply to procedural aspects the federal rule does not preempt — clinical-criteria disclosure, peer-reviewer escalation, language-access requirements — but the appeals timeline and the right-to-file-a-civil-action follow fully from 29 C.F.R. § 2560.503-1 and ERISA § 502(a). A well-built Florida appeal letter cites both: the controlling FL statute (§ 627.6145 / § 627.646 for OIR-regulated plans) or the federal preemption fallback (29 C.F.R. § 2560.503-1 for self-funded ERISA), and the right federal framework underneath.